↓ Skip to main content

Evaluation of RECIST in chemotherapy-treated lung cancer: the Pharmacogenoscan Study

Overview of attention for article published in BMC Cancer, December 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news
1 news outlet
reddit
1 Redditor

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
27 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Evaluation of RECIST in chemotherapy-treated lung cancer: the Pharmacogenoscan Study
Published in
BMC Cancer, December 2014
DOI 10.1186/1471-2407-14-989
Pubmed ID
Authors

Anne-Claire Toffart, Denis Moro-Sibilot, Sébastien Couraud, Patrick Merle, Maurice Perol, Nicolas Girard, Pierre-Jean Souquet, Bénédicte Mastroianni, Gilbert R Ferretti, Philippe Romand, Patrick Chatellain, Aurélien Vesin, Elisabeth Brambilla, Christian Brambilla, Jean-François Timsit

Abstract

Response Evaluation Criteria in Solid Tumors (RECIST) are widely used to assess the effect of chemotherapy in patients with cancer. We hypothesised that the change in unidimensional tumour size handled as a continuous variable was more reliable than RECIST in predicting overall survival (OS).

Mendeley readers

The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 27 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 5 19%
Researcher 4 15%
Other 2 7%
Student > Ph. D. Student 2 7%
Student > Doctoral Student 1 4%
Other 3 11%
Unknown 10 37%
Readers by discipline Count As %
Medicine and Dentistry 8 30%
Agricultural and Biological Sciences 3 11%
Computer Science 2 7%
Biochemistry, Genetics and Molecular Biology 2 7%
Immunology and Microbiology 1 4%
Other 1 4%
Unknown 10 37%

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 December 2014.
All research outputs
#597,198
of 4,691,823 outputs
Outputs from BMC Cancer
#155
of 2,559 outputs
Outputs of similar age
#25,659
of 155,521 outputs
Outputs of similar age from BMC Cancer
#13
of 139 outputs
Altmetric has tracked 4,691,823 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,559 research outputs from this source. They receive a mean Attention Score of 2.4. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 155,521 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 139 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.